CAS: 2178049-58-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ACT-1004-1239 REF: TM-T39665CAS: 2178049-58-4 | 98.31% | 219.00 €~2,804.00 € | Tue 22 Apr 25 |
 | ACT 1004-1239 REF: 3D-FA181705CAS: 2178049-58-4 | Min. 95% | - - - | Discontinued product |
ACT-1004-1239
CAS:2178049-58-4
ACT-1004-1239 is a CXCR7 antagonist with immunomodulatory and myelination-promoting effects, used for research on inflammatory …
Formula:
C27H28F2N6O3
Purity:
98.31%
Color and Shape:
Liquid
Molecular weight:
522.55
Ref: TM-T39665
| 1mg | 219.00 € | ||
| 5mg | 545.00 € | ||
| 10mg | 879.00 € | ||
| 25mg | 1,745.00 € | ||
| 50mg | 2,804.00 € |
Estimated delivery in United States, on Tuesday 22 Apr 2025
ACT 1004-1239
CAS:2178049-58-4
Please enquire for more information about ACT 1004-1239 including the price, delivery time and more …
Formula:
C27H28F2N6O3
Purity:
Min. 95%
Molecular weight:
522.55 g/mol
Ref: 3D-FA181705
| Undefined size | Discontinued | Request information |
